Market Analysis and Size
Hypercoagulability, irregular blood flow, and damage to blood vessel endothelial cells are the three main causes of thrombosis. Genetic disorders, inactivity, smoking, blood vessel disease, pregnancy, and obesity are all contributing factors. Various forms of thrombosis therapies are currently available on the market. Anticoagulants, commonly known as blood thinners, are the first-line treatment for thrombosis. These medications are primarily used to break or dissolve clots through enzymatic action. The main thrombosis medications on the market include Apixaban, Debigatran, Edoxaban, Fondaparinux, Heparin, Rivaroxaban, and Warfarin. Heparin and warfarin medications are predicted to account for the largest market share among all drugs over the forecast period.
Data Bridge Market Research analyses that the antithrombotic drugs market was valued at USD 41,697.49 million in 2021 and is expected to reach USD 76,722.98 million by 2029, registering a CAGR of 7.92% during the forecast period of 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Get PDF Sample of the Report:- https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-antithrombotic-drugs-market
Antithrombotic Drugs Market Dynamics
Drivers
· Increasing prevalence of chronic diseases
The increased prevalence of chronic illness such as cancer, hypertension and cardiac related disorders will fuel industry growth. Cardiovascular diseases (CVDs) are the largest cause of death worldwide, claiming the lives of an estimated 17.9 million people each year. Heart attacks and strokes account for more than four out of every five CVD deaths, with one-third of these deaths occurring before the age of 70.
· Rising number geriatric population
The anti-thrombotic medicines market grew due to the ageing demographic profiles of most countries. According to estimates based on Population Reference Bureau statistics, the number of individuals over 65 in the world increased by 33% between 2014 and 2017, from under 450 million to 601 million. During the forecast period, this tendency is expected to continue. In Japan, the proportion of seniors is predicted to rise from 24% in 2012 to 40% in 2050. The ageing population has increased the number of people who suffer from cardiovascular diseases, which are a leading cause of death.
Furthermore, surging number of government initiatives to spread awareness will result in the expansion of antithrombotic drugs market. Along with this, sedentary lifestyle of people and favourable reimbursement policies will enhance the growth rate of the market. Another significant factor influencing the growth rate of antithrombotic drugs market is the rising healthcare expenditure which helps in improving its infrastructure.
Opportunities
· Growing demand for NOACS
Increased demand for NOACS, as well as government healthcare policies and programmes, are key drivers of growth in the worldwide antithrombotic medicines market. The market is growing due to the rising acceptance of NOACs. To prevent and cure thrombosis, NOACs target either thrombin or factor Xa. They demonstrate fast activity and do not necessitate constant supervision. The administrations of the various regions are taking steps to improve the health of the country. This will provide new market opportunities.
Moreover, the market's growth is fueled by an increase in the number of research and development activities for the new drug development and new product launches. These factors will provide beneficial opportunities for the antithrombotic drugs market growth.
Global Antithrombotic Drugs Market Scope
The antithrombotic drugs market is segmented on the basis of type, drug class, and indication, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
· Apixaban
· Debigatran
· Edoxaban
· Fondaparinux
· Heparin
· Rivaroxaban
Indication
· Atrial Fibrillation
· Stroke
· Deep vein thrombosis (DVT)
· Pulmonary Embolism (PE)
· Others
Drug Class
· Thrombolytic Drugs
· Anti-Platelet Drugs
· Anticoagulants
· Others
Route of Administration
· Oral
· Injectable
· Others
End-Users
· Hospitals
· Specialty Clinics
· Homecare
· Others
Distribution Channel
· Hospital Pharmacy
· Retail Pharmacy
· Online Pharmacy
· Others
Get TOC Details of the Report:- https://www.databridgemarketresearch.com/toc/?dbmr=global-antithrombotic-drugs-market
Antithrombotic Drugs Market Regional Analysis/Insights
The antithrombotic drugs market is analysed and market size insights and trends are provided by country, type, drug class, indication, route of administration, end-users and distribution channel as referenced above.
The countries covered in the antithrombotic drugs market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
North America dominates the antithrombotic drugs market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the growing cardiac and cancer diseases and rising healthcare expenditure will further propel the market’s growth rate in this region. Additionally, growing presence of major key players and rise in adoption of newer technologies will further propel the market’s growth rate in this region.
Asia-Pacific is expected to be the fastest growing region during the forecast period of 2022-2029 due to surging number of geriatric population in this region. Also, development of healthcare infrastructure and rising government initiatives will further propel the market’s growth rate in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Antithrombotic Drugs Market Share Analysis
The antithrombotic drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to antithrombotic drugs market.
Some of the major players operating in the antithrombotic drugs market are:
· F. Hoffmann-La Roche Ltd. (Switzerland)
· Mylan N.V. (U.S.)
· Teva Pharmaceutical Industries Ltd. (Ireland)
· Sanofi (France)
· Pfizer Inc. (U.S.)
· GlaxoSmithKline plc (U.K.)
· Novartis AG (Switzerland)
· Merck & Co., Inc. (U.S.)
· Allergan (Ireland)
· AstraZeneca (U.K.)
· Johnson & Johnson Private Limited (U.S.)
· Hikma Pharmaceuticals PLC (U.K.)
· Fresenius Kabi AG (Germany)
· Eisai Co., Ltd. (Japan)
· Bristol-Myers Squibb Company (U.S.)
· Bayer AG (Germany)
· DAIICHI SANKYO COMPANY, LIMITED (Japan)
· Boehringer Ingelheim International GmbH. (Germany)
· Dr. Reddy’s Laboratories Ltd. (India)
· Aspen Holdings (South Africa)
Browse in-depth Research Report:- https://www.databridgemarketresearch.com/reports/global-antithrombotic-drugs-market
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.
Top Trending’s Report:-
Healthcare Biometrics Market – Industry Trends and Forecast to 2029 | Data Bridge Market Research https://www.databridgemarketresearch.com/reports/global-healthcare-biometrics-market
Brain Monitoring Devices Market – Industry Trends and Forecast to 2029 | Data Bridge Market Research https://www.databridgemarketresearch.com/reports/global-brain-monitoring-devices-market
Single Tooth Implants and Dental Bridges Market Growth, Demand, Size, & Forecast To 2029 https://www.databridgemarketresearch.com/reports/global-single-tooth-implants-and-dental-bridges-market
Depth Filtration Market –Industry Trends and Forecast to 2029 | Data Bridge Market Research https://www.databridgemarketresearch.com/reports/global-depth-filtration-market
Medical Gloves Market Size, Share, Research, & Forecast To 2029 https://www.databridgemarketresearch.com/reports/global-medical-gloves-market
About Data Bridge Market Research, Private Ltd
Data Bridge Market Research Pvt Ltd is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.
Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expands their reach by opening a new office in Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. “Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated Team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve.”
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: - Corporatesales@databridgemarketresearch.com
